Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Endocrinology · Gastrinoma

The Science Behind Your Diagnosis: Biology and Genetics

At a Glance

A gastrinoma is a hormone-producing tumor that releases too much gastrin, driving excess stomach acid, ulcers, and diarrhea. MEN1 testing is recommended because inherited disease can cause multiple tumors and requires ongoing parathyroid, pituitary, and abdominal monitoring.

Understanding how a gastrinoma works in your body helps explain why the symptoms are so intense and why your care team needs to look at more than just the tumor itself.

The Biological Chain Reaction

A gastrinoma is a neuroendocrine tumor, meaning it is made of cells that produce hormones [1]. In this case, the tumor releases massive amounts of a hormone called gastrin.

In a healthy body, gastrin is released in small amounts to tell the stomach to produce acid for digestion. In your case, the tumor acts like a “broken faucet” that is stuck on high [2]. This leads to a three-step chain reaction:

  1. The Surge: The tumor floods your bloodstream with gastrin [1].
  2. The Overdrive: The gastrin attaches to receptors in your stomach, causing acid-producing cells to grow and work overtime. This state is called gastric acid hypersecretion [1][3].
  3. The Damage: The stomach produces massive amounts of acid that overwhelms the protective lining of your intestines, creating deep ulcers and causing diarrhea because the acid prevents food from being digested properly [3][2].

Two Different Paths: Sporadic vs. MEN1

Doctors divide gastrinomas into two main categories. Knowing which one you have is vital because it changes your long-term monitoring plan.

  • Sporadic Gastrinoma (About 80% of cases): These occur “out of the blue” and are not linked to an inherited gene [4]. They are typically solitary (one single tumor). While most gastrinomas are duodenal, sporadic tumors in the pancreas are less common but may sometimes be larger or more aggressive [5][6].
  • MEN1-Associated Gastrinoma (About 20% of cases): These are caused by a genetic condition called Multiple Endocrine Neoplasia type 1 (MEN1) [7]. These tumors are almost exclusively duodenal, often tiny, and “multifocal,” meaning there are many small tumors located throughout the duodenum [8][6].

Why Genetic Testing is Recommended

Experts recommend that every person diagnosed with a gastrinoma be evaluated for MEN1, even if they have no family history of the disease [9][10]. This is because MEN1 is a syndrome that can affect three different areas of the body:

  1. Parathyroid: Overactive glands that cause high blood calcium, which can lead to kidney stones [9].
  2. Pituitary: Small tumors in the brain that can affect other hormones [9].
  3. Pancreas/Duodenum: Where gastrinomas and other neuroendocrine tumors grow [9].

Genetic counseling and testing is a simple blood test. If you test positive for the MEN1 gene, your doctors will perform a guideline-based combination of biochemical tests (like calcium/PTH and pituitary hormones) and periodic pituitary and abdominal imaging to catch any other issues early [7][11]. It also provides important information for family cascade testing, where relatives can be tested for the specific confirmed familial variant [9].

Why Doctors Run So Many Tests

You may have noticed your doctors repeating blood tests or performing different types of scans. This is because hypergastrinemia (high gastrin in the blood) has several “mimics” that are not tumors [12]:

  • PPI Medications: Common acid-blockers like omeprazole intentionally raise gastric pH, causing your body to produce more gastrin as it tries to overcome the medication [7].
  • Atrophic Gastritis or Achlorhydria: In these conditions, the stomach’s acid cells are damaged or dead. The body senses there is no acid and sends out huge amounts of gastrin to compensate [13].
  • H. pylori Infection: This common stomach bacteria can sometimes disrupt gastrin levels [14].

The classic pattern for confirming ZES is finding a markedly elevated gastrin level (often more than 10 times the normal limit) at the same time as a very low (acidic) stomach pH (at or below 2.0) [15]. However, because PPIs and other conditions complicate these results, pH and gastrin levels must be interpreted together by specialists, sometimes requiring a secretin stimulation test [15][13]. A high pH makes active acid hypersecretion less likely, but it does not completely rule out a gastrinoma without further investigation.

Common questions in this guide

How does a gastrinoma cause ulcers and diarrhea?
A gastrinoma releases too much gastrin, a hormone that signals the stomach to produce acid. Excess acid can damage the digestive tract and cause deep ulcers, while also interfering with digestion and contributing to diarrhea.
What is the difference between sporadic and MEN1-associated gastrinoma?
Sporadic gastrinomas are not linked to an inherited gene and are usually single tumors. MEN1-associated gastrinomas result from an inherited condition and are often many small tumors in the duodenum.
Why is MEN1 testing recommended after a gastrinoma diagnosis?
MEN1 can affect the parathyroid glands, pituitary gland, and pancreas or duodenum, even when there is no known family history. Identifying MEN1 helps guide long-term monitoring and allows relatives to discuss targeted family testing.
Can proton pump inhibitors affect a gastrin test?
Yes. Proton pump inhibitors, such as omeprazole, reduce stomach acid, which can cause the body to raise gastrin levels even when a tumor is not present. A specialist must interpret gastrin results alongside medication use and stomach acidity, and you should not stop a prescribed medicine without medical advice.
What tests help confirm Zollinger-Ellison syndrome caused by a gastrinoma?
Doctors typically interpret a markedly high gastrin level together with a very acidic stomach pH. Because medications and other stomach conditions can produce similar results, testing may also include a secretin stimulation test and additional evaluation by specialists.
What monitoring is needed if a gastrinoma is linked to MEN1?
Monitoring may include blood tests for calcium, parathyroid hormone, and pituitary hormones, along with periodic pituitary and abdominal imaging. Genetic counseling can also help relatives understand whether targeted testing is appropriate.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my scans and endoscopy, do I have a single tumor or multiple small ones?
  2. 2.Have you checked my blood calcium and parathyroid hormone (PTH) levels recently?
  3. 3.Should I be referred to a genetic counselor to discuss testing for the MEN1 gene?
  4. 4.If I have the MEN1 subtype, how does that change the way you monitor my pituitary and parathyroid glands?
  5. 5.Are there any other conditions, like H. pylori or atrophic gastritis, that you have ruled out before confirming my diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Gastric acid secretion.

    Schubert ML

    Current opinion in gastroenterology 2016; (32(6)):452-460 doi:10.1097/MOG.0000000000000308.

    PMID: 27607343
  2. 2

    Diarrhea, Weight Loss, and an Elevated Gastrin: A Case Report.

    Alexander RG, Cheville JC, Thompson GB, Alexander GL

    Case reports in gastroenterology 2025; (19(1)):428-433 doi:10.1159/000545714.

    PMID: 40503451
  3. 3

    Diagnosis and management of Zollinger-Ellison syndrome in 2018.

    De Angelis C, Cortegoso Valdivia P, Venezia L, et al.

    Minerva endocrinologica 2018; (43(2)):212-220 doi:10.23736/S0391-1977.17.02745-6.

    PMID: 28949124
  4. 4

    De novo Gastrinoma: A Case Report.

    Barbosa A, Gomes F, Fonseca L, et al.

    GE Portuguese journal of gastroenterology 2020; (27(3)):192-196 doi:10.1159/000503073.

    PMID: 32509925
  5. 5

    Clinicopathological characteristics and prognosis analysis of gastrinoma based on the SEER database.

    Qiu C, Hu C, Lu C, et al.

    PloS one 2025; (20(12)):e0337940 doi:10.1371/journal.pone.0337940.

    PMID: 41406116
  6. 6

    [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].

    Guo Y, Chen LH, Liu M, et al.

    Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2021; (24(10)):875-882 doi:10.3760/cma.j.cn.441530-20210719-00291.

    PMID: 34674462
  7. 7

    Assessing for Multiple Endocrine Neoplasia Type 1 in Patients Evaluated for Zollinger-Ellison Syndrome-Clues to a Safer Diagnostic Process.

    Singh Ospina N, Donegan D, Rodriguez-Gutierrez R, et al.

    The American journal of medicine 2017; (130(5)):603-605 doi:10.1016/j.amjmed.2016.11.035.

    PMID: 28011308
  8. 8

    Contemporary surgical management of the Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1.

    Albers MB, Manoharan J, Bartsch DK

    Best practice & research. Clinical endocrinology & metabolism 2019; (33(5)):101318 doi:10.1016/j.beem.2019.101318.

    PMID: 31521501
  9. 9

    Multiple Endocrine Neoplasia Type 1 Presenting as Recurrent Overt Gastrointestinal Bleeding and Ulceration: A Diagnostic Challenge.

    Sanjana VI, Fahim J, Sekander A, Rameshshanker R

    Cureus 2025; (17(12)):e99252 doi:10.7759/cureus.99252.

    PMID: 41541958
  10. 10

    Multiple endocrine neoplasia type 1 with Zollinger-Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry.

    Kimura N, Hirata Y, Iwashiro N, et al.

    Frontiers in endocrinology 2023; (14()):1221514 doi:10.3389/fendo.2023.1221514.

    PMID: 37867522
  11. 11

    Multiple Endocrine Neoplasia Type 1 (MEN1) Presenting as an Invasive Macroprolactinoma Complicated by Acute Bacterial Meningitis.

    Bandaru S, Jaju A, Manthri S, et al.

    Cureus 2021; (13(12)):e20086 doi:10.7759/cureus.20086.

    PMID: 34993034
  12. 12

    Gastric Hypersecretory States: Investigation and Management.

    Phan J, Benhammou JN, Pisegna JR

    Current treatment options in gastroenterology 2015; (13(4)):386-97 doi:10.1007/s11938-015-0065-8.

    PMID: 26342486
  13. 13

    Type-1 Grade 2 Multi-Focal Gastric Neuroendocrine Tumors Secondary to Chronic Autoimmune Gastritis.

    Yu Z, Wang A, Hu C, et al.

    Frontiers in medicine 2022; (9()):856125 doi:10.3389/fmed.2022.856125.

    PMID: 35783638
  14. 14

    The Relationship of Gastrinoma in MEN 1 to Helicobacter pylori infection.

    Endall R, Thompson M, Parameswaran V, Burgess J

    The Journal of clinical endocrinology and metabolism 2020; (105(3)) doi:10.1210/clinem/dgaa004.

    PMID: 31919513
  15. 15

    All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.

    Chatzipanagiotou O, Schizas D, Vailas M, et al.

    Journal of neuroendocrinology 2023; (35(4)):e13267 doi:10.1111/jne.13267.

    PMID: 37042078

This page explains gastrinoma biology, MEN1, and diagnostic testing for informational purposes only and does not constitute medical advice. Your specialist team should interpret your gastrin, stomach pH, imaging, and genetic results.

Get notified when new evidence is published on gastrin-producing neuroendocrine tumor.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.